D'AMELIO, MARCELLO
 Distribuzione geografica
Continente #
AS - Asia 4.818
NA - Nord America 2.353
EU - Europa 869
SA - Sud America 155
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 39
OC - Oceania 9
Totale 8.303
Nazione #
SG - Singapore 3.618
US - Stati Uniti d'America 2.277
CN - Cina 593
IT - Italia 421
HK - Hong Kong 341
GB - Regno Unito 154
FR - Francia 109
BR - Brasile 97
IN - India 62
VN - Vietnam 54
DE - Germania 46
CA - Canada 38
NL - Olanda 30
BD - Bangladesh 24
CO - Colombia 20
ZA - Sudafrica 20
TR - Turchia 18
MX - Messico 17
EC - Ecuador 14
FI - Finlandia 14
ES - Italia 13
LU - Lussemburgo 13
AR - Argentina 12
JP - Giappone 12
SA - Arabia Saudita 12
ID - Indonesia 11
IQ - Iraq 10
UA - Ucraina 10
AU - Australia 9
RU - Federazione Russa 9
JO - Giordania 8
PH - Filippine 8
PL - Polonia 8
PK - Pakistan 7
LT - Lituania 6
MA - Marocco 6
SE - Svezia 6
UZ - Uzbekistan 6
JM - Giamaica 5
TW - Taiwan 5
VE - Venezuela 5
AL - Albania 4
IR - Iran 4
MD - Moldavia 4
OM - Oman 4
TN - Tunisia 4
AT - Austria 3
CR - Costa Rica 3
DZ - Algeria 3
EE - Estonia 3
HN - Honduras 3
HU - Ungheria 3
KR - Corea 3
MY - Malesia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
EG - Egitto 2
GR - Grecia 2
GT - Guatemala 2
HT - Haiti 2
IE - Irlanda 2
LV - Lettonia 2
MK - Macedonia 2
NP - Nepal 2
PT - Portogallo 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GD - Grenada 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
PS - Palestinian Territory 1
PY - Paraguay 1
RW - Ruanda 1
SN - Senegal 1
UY - Uruguay 1
Totale 8.246
Città #
San Jose 693
Ashburn 483
Singapore 423
Hong Kong 337
Rome 293
Hefei 203
Council Bluffs 159
London 131
Beijing 129
Boardman 129
Columbus 119
Lauterbourg 91
Shanghai 72
Santa Clara 42
Dallas 41
Los Angeles 35
Phoenix 32
Milan 30
New York 26
San Francisco 23
Pune 19
Seattle 17
Chennai 15
Hanoi 13
São Paulo 13
Washington 13
Amsterdam 12
Atlanta 12
Ho Chi Minh City 12
Montreal 12
Munich 12
Tokyo 11
Frankfurt am Main 10
Johannesburg 10
Toronto 10
Brooklyn 9
Naples 9
Buffalo 8
Quito 8
Amman 7
Chicago 7
Dudelange 7
Mexico City 7
Riyadh 7
Suzhou 7
Bogotá 6
Charlotte 6
Helsinki 6
Luxembourg 6
Orem 6
Stockholm 6
Turku 6
Houston 5
Huntington Beach 5
Kingston 5
Las Vegas 5
Paris 5
Cagliari 4
Florence 4
Haikou 4
Manchester 4
Muscat 4
New Delhi 4
Polska 4
Qingdao 4
Sydney 4
Tashkent 4
The Dalles 4
Tirana 4
Warsaw 4
Bari 3
Bologna 3
Canberra 3
Changsha 3
Curitiba 3
Guayaquil 3
Hangzhou 3
Istanbul 3
Lima 3
Medellín 3
Miami 3
Montes Claros 3
Mumbai 3
Pittsburgh 3
Rio de Janeiro 3
Tainan 3
Tallinn 3
Trieste 3
Xi'an 3
Yalova 3
Ankara 2
Baghdad 2
Baltimore 2
Bangkok 2
Berlin 2
Brasília 2
Bridgetown 2
Budapest 2
Buenos Aires 2
Cairo 2
Totale 3.957
Nome #
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (Nature Communications, (2019), 10, 1, (3945), 10.1038/s41467-019-11928-w) 233
Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism 229
Cisd2: a promising new target in Alzheimer's disease† 215
Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease 214
Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice 210
Apoptosome pharmacological manipulation: from current developments in the laboratory to clinical implications 208
Alzheimer's Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model 207
A novel player in the p53-mediated autophagy: Sestrin2 205
Hippocampal epileptogenesis in autoimmune encephalitis. 199
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models 195
BODIPY-Based Analogue of the TREM2-Binding Molecular Adjuvant Sulfavant A, a Chemical Tool for Imaging and Tracking Biological Systems 176
A New Transgenic Mouse Model for Studying the Neurotoxicity of Spermine Oxidase Dosage in the Response to Excitotoxic Injury. 170
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease 165
Ambra1 shapes hippocampal inhibition/excitation balance: role in neurodevelopmental disorders 128
Autophagy Inhibition Favors Survival of Rubrospinal Neurons After Spinal Cord Hemisection. 119
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease 118
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. 117
Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia. 117
Apoptosome: An Up-and-coming Therapeutical Tool 117
Age-Related Changes of Hippocampal Synaptic Plasticity in AβPP-Null Mice are Restored by NGF through p75NTR 115
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis. 114
Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease 113
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease 113
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 107
Aβ toxicity in Alzheimer's disease 106
Astrocyte-Dependent Vulnerability to Excitotoxicity in Spermine Oxidase-Overexpressing Mouse 103
Acute focal brain damage alters mitochondrial dynamics and autophagy in axotomized neurons 100
Analysis of neuronal cell death in mammals 100
Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model 100
AUTOPHAGY ENHANCING COMPOUNDS, PEPTIDES AND PEPTIDOMIMETIC COMPOUNDS FOR USE IN THE TREATMENT OF NEURONAL DISEASES 95
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice 92
Neuroprotective Role of Dietary Supplementation with Omega-3 Fatty Acids in the Presence of Basal Forebrain Cholinergic Neurons Degeneration in Aged Mice 83
Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives 81
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease 80
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases 79
Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer’s Disease 79
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease 77
Neuronal caspase-3 signalling: not only cell death 74
Haploinsufficiency of PDE2A causes in mice increased exploratory behavior associated with upregulation of neural nitric oxide synthase in the striatum 73
Repetitive prefrontal tDCS activates VTA dopaminergic neurons, resulting in attenuation of Alzheimer's Disease-like deficits in Tg2576 mice 69
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 69
The "Janus-Faced Role" of Autophagy in Neuronal Sickness: Focus on Neurodegeneration. 67
A dual role of p53 in the control of autophagy 64
Restoration of ER proteostasis attenuates remote apoptotic cell death after spinal cord injury by reducing autophagosome overload 62
On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area. 62
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease. 57
Clarifying the role of D1 receptor signalling in Alzheimer's-related epilepsy commentary on Szabo et al. (2024) 55
Dopaminergic deficits along the spectrum of Alzheimer's disease 54
Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans. 54
Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings. 51
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 51
Targeting autophagy as a therapeutic strategy to prevent dopamine neuron loss in early stages of Alzheimer disease 50
Insulin Receptor β-Subunit Haploinsufficiency Impairs Hippocampal Late-Phase LTP and Recognition Memory 50
Faf1 is expressed during neurodevelopment and is involved in Apaf1-dependent caspase-3 activation in proneural cells 49
Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage 49
Neuregulin 1/ErbB signalling modulates hippocampal mGluRI-dependent LTD and object recognition memory. 48
Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats 48
Caspase-3 in the central nervous system: beyond apoptosis. 47
Role of Autophagy in Brain Sculpture: Physiological and Pathological Implications 47
Early Biochemical and Morphological Modifications in the Brain of a Transgenic Mouse Model of Alzheimer's Disease: A Role for Peroxisomes 47
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 47
Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease. 46
Ventral tegmental area dysfunction affects decision-making in patients with myotonic dystrophy type-1 46
Key role of mitochondria in Alzheimer’s Disease synaptic dysfunction 45
Nilotinib: from animal-based studies to clinical investigation in Alzheimer's disease patients 44
Ventral tegmental area disruption in Alzheimer's disease. 44
Regulation of autophagy by cytoplasmic p53 44
Matter of life and death: the pharmacological approaches targeting apoptosis in brain diseases. 44
Interactions between neuroactive steroids and reelin haploinsufficiency in Purkinje cell survival 44
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases 44
Guidelines for the use and interpretation of assays for monitoring autophagy. 43
CONDITIONAL ACTIVATION OF PAX6 IN THE DEVELOPING CORTEX OF TRANSGENIC MICE CAUSES PROGENITOR APOPTOSIS 43
Mutations in the TMPRSS3 gene are a rare cause of childhood nonsyndromic deafness in Caucasian patients 43
In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease 43
Emerging role of mitochondria dysfunction in the onset of neurodegenerative diseases. 43
Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons 43
Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions 43
Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to alzheimer's disease: Implications for treatment 43
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development 42
RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models. 42
Nonapoptotic role for Apaf-1 in the DNA damage checkpoint 42
Sam68 splicing regulation contributes to motor unit establishment in the postnatal skeletal muscle 41
Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration. 41
Transient upregulation of translational efficiency in prodromal and early symptomatic Tg2576 mice contributes to Aβ pathology 40
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. 40
The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy 40
Neuroprotective effects of donepezil against cholinergic depletion. 39
TRANSMISSION DISEQUILIBRIUM STUDY OF AN OLIGODENDROCYTE AND MYELIN GLYCOPROTEIN GENE ALLELE IN 431 FAMILIES WITH AN AUTISTIC PROBAND 39
CREB is necessary for synaptic maintenance and learning-induced changes of the AMPA receptor GluA1 subunit. 39
Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer disease? 38
Unlocking the secrets of dopamine in Alzheimer's Disease. 38
Interactions genes-environnement dans la pathogénie de l’autisme 38
Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer's Disease 38
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 37
Schwann cell autophagy counteracts the onset and chronification of neuropathic pain. 36
SAM68 is a physiological regulator of SMN2 splicing in spinal muscular atrophy 36
Targeting Synaptic Dysfunction and Neural Connectivity in Neurological and Psychiatric disorders 36
Microfluidic-Based Technologies for Crossing the Blood–Brain Barrier Against Alzheimer’s Disease: Novel Strategies and Challenges 35
The role of dopaminergic midbrain in Alzheimer's disease: Translating basic science into clinical practice. 34
Physiological and Pathological Role of Apoptosis 34
Totale 8.013
Categoria #
all - tutte 55.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 0 1 0 2 1 11 4 5 3 111
2022/202389 3 0 41 2 4 0 0 0 1 0 33 5
2023/2024360 9 58 13 40 34 164 1 19 5 4 6 7
2024/20253.987 62 19 119 21 22 109 35 31 260 301 1.335 1.673
2025/20263.023 363 92 50 195 131 226 1.056 161 212 301 163 73
2026/2027703 57 323 275 48 0 0 0 0 0 0 0 0
Totale 8.303